China Meheco(SH:600056) Zhong Guo Ji Jin Bao·2025-12-26 10:26Group 1 - The former Party Secretary and Chairman of China National Pharmaceutical Group, Gao Yuwen, is under investigation for serious violations of discipline and law [1][4] - Gao Yuwen held various positions within the company from 2008 to 2021, including General Manager and Party Secretary, before resigning as Chairman in February 2021 [4] - In the most recent financial report, China National Pharmaceutical Group reported a revenue of 25.894 billion yuan for the first three quarters of the year, a year-on-year decrease of 3.42%, and a net profit attributable to shareholders of 455 million yuan, down 4.64% year-on-year [4] Group 2 - As of December 26, the stock price of China National Pharmaceutical Group was 10.47 yuan per share, reflecting a decrease of 0.38%, with a market capitalization of 15.7 billion yuan [5] - The company is a subsidiary of the General Technology Group and has evolved into a comprehensive platform for pharmaceutical and medical device production and operation [4]